Xie, Jing, Liu, Zeye, Ren, Liqun, He, Liyun, Lu, Shan, Meng, Xiangzhi, Zhang, Xin, Su, Zhanhao, Jing, Shenqi, Shan, Tao, Wang, Junjie, Xia, Ruibing, Feng, Wei, Li, Yakun, Liu, Naifeng, and Liu, Yun
Additional file 1: Figure S1. Rapid causes of cancer mortality worldwide for females and males, 1990–2019. Figure S2. Tracheal, bronchus, and lung cancer age-standardized mortality rates in 2019 (A) and percent change (%) in age-standardized rates during 1990–2019 (B) for 204 countries and territories by sociodemographic index. Figure S3. The colon and rectal cancer age-standardized mortality rates in 2019 (A) and percent change (%) in the age-standardized rate during 1990–2019 (B) for 204 countries and territories by sociodemographic index. Figure S4. Breast cancer age-standardized mortality rates in 2019 (A) and percent change (%) in age-standardized rates during 1990–2019 (B) for 204 countries and territories by sociodemographic index. Figure S5. Pancreatic cancer age-standardized mortality rates in 2019 (A) and percent change (%) in age-standardized rates during 1990–2019 (B) for 204 countries and territories by sociodemographic index. Figure S6. Local drifts of tracheal, bronchus, and lung cancer mortality attributable to HFPG by SDI quintiles, 1990–2019. Figure S7. Local drifts of colon and rectal cancer mortality attributable to HFPG by SDI quintiles, 1990–2019. Figure S8. Local drifts of breast cancer mortality attributable to HFPG by SDI quintiles, 1990–2019. Figure S9. Local drifts of pancreatic cancer mortality attributable to HFPG by SDI quintiles, 1990–2019. Figure S10. Age distribution of tracheal, bronchus, and lung cancer mortality attributable to HFPG by SDI quintiles, 1990–2019. Figure S11. Age distribution of colon and rectal cancer mortality attributable to HFPG by SDI quintiles, 1990–2019. Figure S12. Age distribution of breast cancer mortality attributable to HFPG by SDI quintiles, 1990–2019. Figure S13. Age distribution of pancreatic cancer mortality attributable to HFPG by SDI quintiles, 1990–2019. Figure S14. Age, period and cohort effects on tracheal, bronchus, and lung cancer mortality attributable to HFPG by SDI quintiles. Figure S15. Age, period and cohort effects on colon and rectal cancer mortality attributable to HFPG by SDI quintiles. Figure S16. Age, period and cohort effects on breast cancer mortality attributable to HFPG by SDI quintiles. Figure S17. Age, period and cohort effects on pancreatic cancer mortality attributable to HFPG by SDI quintiles. Figure S18. Age, period and cohort effects on tracheal, bronchus, and lung cancer mortality attributable to HFPG for representative countries. Figure S19. Age, period and cohort effects on colon and rectal cancer mortality attributable to HFPG for representative countries. Figure S20. Age, period and cohort effects on breast cancer mortality attributable to HFPG for representative countries. Figure S21. Age, period and cohort effects on pancreatic cancer mortality attributable to HFPG for representative countries. Table S1. Percent changes (%) in the age-standardized mortality rate 1990–2019 for all risk factors. Table S2. Trends in cancer mortality attributable to HPFG for females and males across SDI quintiles, 1990 − 2019. Table S3. Trends in tracheal, bronchus, and lung cancer mortality attributable to HPFG for both females and males across SDI quintiles, 1990 − 2019. Table S4. Trends in colon and rectal cancer mortality attributable to HPFG for both females and males across SDI quintiles, 1990 − 2019. Table S5. Trends in breast cancer mortality attributable to HPFG for female across SDI quintiles, 1990 − 2019. Table S6. Trends in pancreatic cancer mortality attributable to HPFG for both females and males across SDI quintiles, 1990 − 2019. Table S7. Trends in cancer mortality attributable to HPFG for both genders in 204 countries and regions, 1990–2019. Table S8. Trends in cancer mortality attributable to HPFG for both females and males in representative countries, 1990–2019. Table S9. Trends in tracheal, bronchus, and lung cancer mortality attributable to HPFG for both females and males in representative countries, 1990–2019. Table S10. Trends in colon and rectal cancer mortality attributable to HPFG for both females and males in representative countries, 1990–2019. Table S11. Trends in breast cancer mortality attributable to HPFG for both females in representative countries, 1990–2019. Table S12. Trends in pancreatic cancer mortality attributable to HPFG for both females and males in representative countries, 1990–2019.